Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease
By K. D. de Lange, L. Moutsianas, James C. Lee, C. Lamb, Yang Luo, N. Kennedy, L. Jostins, D. Rice, Javier Gutiérrez-Achury, S. Ji and 22 more. Nature Genetics, 2016
1,230 citations recorded by the source corpus.
Genetic association studies have identified 215 risk loci for inflammatory bowel disease, thereby uncovering fundamental aspects of its molecular biology. We performed a genome-wide association study of 25,305 individuals and conducted a meta-analysis with published summary statistics, yielding a total sample size of 59,957 subjects. We identified 25 new susceptibility loci, 3 of which contain integrin genes that encode proteins in pathways that have been identified as important therapeutic targets in inflammatory bowel disease. The associated variants are correlated with expression changes in response to immune stimulus at two of these genes (ITGA4 and ITGB8) and at previously implicated loci (ITGAL and ICAM1). In all four cases, the expression-increasing allele also increases disease risk. We also identified likely causal missense variants in a gene implicated in primary immune deficiency, PLCG2, and a negative regulator of inflammation, SLAMF8. Our results demonstrate that new associations at common variants continue to identify genes relevant to therapeutic target identification and prioritization.
Subfields: Genetics, Immunology, Infectious Diseases
View Paper: https://www.semanticscholar.org/paper/fa9ab19c55f7296ab309f43ecc6434a3458a0de0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
- George Davey Smith
- Stephen Burgess
- Gibran Hemani
- J. Bowden
- Michael Holmes
- S. Thompson
- Philip C. Haycock
- Mark J. Daly
In Immunology
Citations in the corpus
- Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics (2020, methodology): “The study-trait page in the Open Targets Portal for the associated trait inflammatory bowel disease from the study (22).”
- Genome-wide enhancer maps link risk variants to disease genes (2021, methodology): “We also analysed variants from IBD GWAS loci that were not fine-mapped in this study 51,52 ; for each such locus, we analysed all variants from the 1000 Genomes Project in linkage disequilibrium with the lead variant ( r 2 > 0.2) and weighted each variant evenly (probability = 1/number of variants…”
- Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases (2019, background): “There were four conditionally independent signals (conditional P < 1 x 10) predicted for Crohn’s disease in the same region (data from de Lange et al.(31)).”
- A statistical framework for cross-tissue transcriptome-wide association analysis (2018, methodology): “Therefore, in addition to 44 tissues from GTEx, we also incorporated liver eQTL from STARNET and both eQTL and splicing (s)QTL data in three immune cell types (that”